Castellarin, Mauro
Watanabe, Keisuke
June, Carl H. http://orcid.org/0000-0003-0241-3557
Kloss, Christopher C.
Posey, Avery D. Jr.
Article History
Received: 26 October 2017
Revised: 28 December 2017
Accepted: 15 January 2018
First Online: 7 June 2018
Compliance with ethical standards
:
: CHJ reports grants from Novartis, outside the submitted work. In addition, CHJ has a patent 9464140, 9161971, 8975071, 8916381, and 8906682, with royalties paid to Novartis, is a scientific founder of Tmunity Therapeutics, a biotech dedicated to developing engineered T cells for therapy of cancer, infections and autoimmunity, and has founders stock from Tmunity. CCK has ownership interests in patents held by Memorial Sloan-Kettering Cancer Center and licensed to Juno Therapeutics and Fate Therapeutics. ADP is an inventor on intellectual property owned by the University of Pennsylvania. The remaining authors declare that they have no conflict of interest.